HK Stock Market Move | SSY GROUP (02005) fell more than 7%, it is expected that the net profit for the year 2025 will decrease by about 45% to 60% year-on-year.

date
09:45 20/02/2026
avatar
GMT Eight
The Stone Pharmaceutical Group (02005) fell more than 7%, at the time of writing, down 7.28% to HK$2.8, with a turnover of HK$257.58 million.
SSY GROUP (02005) fell by over 7%, as of the time of publication, it fell by 7.28% to HK$2.8, with a turnover of HK$2,575,800. In terms of news, SSY GROUP announced that it is expecting a 45%-60% decrease in net profit for the fiscal year 2025 compared to the previous year's HK$1.061 billion. This is mainly due to the strong demand for intravenous infusion and other drugs in the first quarter of 2024 due to a domestic flu outbreak, but the overall annual performance for the year ending December 31, 2025 was affected by a decrease in drug sales due to the absence of a large-scale epidemic in the country and cost controls under medical insurance; the expansion of various forms of centralized drug procurement (including national and local alliance procurement) and intensified competition in the industry domestically and abroad leading to continued price pressures; and a decrease in revenue for the bromhexine hydrochloride ampoule injection due to no longer being sold through national centralized drug procurement.